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PENGHASILAN RETIKULOSIT DARIPADA SEL STEM 
HEMATOPOIETIK CD34+ YANG BERASAL DARIPADA DARAH TALI 
PUSAT MANUSIA UNTUK PENGKULTURAN Plasmodium knowlesi 




Kemunculan parasit malaria zoonotik, P. knowlesi menjadi parasit paling 
dominan yang menyebabkan jangkitan malaria pada manusia di Asia Tenggara dan 
Borneo Malaysia mencatatkan kes malaria tertinggi yang disebabkan oleh P. knowlesi. 
P. knowlesi dilaporkan menunjukkan kecenderungan terhadap retikulosit. Walau 
bagaimanapun, bagi mendapatkan retikulosit dalam jumlah yang besar untuk bekalan 
berterusan menjadi halangan utama bagi kajian jangka panjang pengkulturan. Ini 
disebabkan oleh kepekatan retikulosit yang rendah dalam darah periferal, sumsum 
tulang dan darah tali pusat. Mujurlah, sistem pembangunan dalam kultur secara in vitro 
untuk menghasilkan retikulosit yang berasal daripada sel stem hematopoietik (HSC) 
dapat menyelesaikan halangan kajian P. knowlesi. Dalam kajian ini, darah tali pusat 
(UCB) digunakan sebagai sumber HSC kerana ia mengandungi kepekatan CD34+ 
tertinggi berbanding darah periferal dan sumsum tulang. Pertama, CD34+ HSC yang 
berasal dari UCB dikembangkan dalam serum-free expansion medium II (SFEM) 
dengan faktor pertumbuhan dan sitokin yang membolehkan sel berkembang biak. 
Setelah sel membiak selama 5 hari, sel telah dikultur dalam media pembezaan dengan 
tambahan faktor pertumbuhan dan sitokin yang mencukupi untuk proses pembezaan 
retikulosit. Pemeriksaan mikroskopik dan analisis FACS telah dijalankan sepanjang 
tempoh pengkulturan bagi memerhati perubahan morfologi dan memantau ekspresi 
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antigen permukaan sel. Akhir sekali, P. knowlesi telah dikultur dalam retikulosit yang 
dihasilkan dan kadar jangkitan ditentukan selepas 24 jam pasca-jangkitan. Walaupun 
jangkitan P. knowlesi tidak dapat dijalankan kerana keadaan yang tidak mengizinkan, 
hasil kajian menunjukkan bahawa retikulosit yang berfungsi dapat dihasilkan dari 
CD34+ HSC yang berasal dari UCB dan kadar jangkitan P. knowlesi dianggarkan sama 
dengan jangkitan P. vivax. Hal ini kerana, P. knowlesi mempunyai filogenetik yang 
hampir sama dengan P. vivax. Sebagai kesimpulan, kajian ini menunjukkan 
kebarangkalian dalam menghasilkan pengeluaran populasi retikulosit homogen secara 




GENERATION OF RETICULOCYTES DERIVED FROM HUMAN 
UMBILICAL CORD BLOOD CD34+ HAEMATOPOIETIC STEM CELLS 




The emergence of zoonotic malaria parasite, P. knowlesi becomes the most 
dominant parasite causing malaria infection in humans in the Southeast Asia where 
Malaysian Borneo has recorded to have the highest cases of malaria diseases caused 
by P. knowlesi. It has been reported that P. knowlesi shows preference towards 
reticulocytes. However, obtaining a huge amount of reticulocytes for the continuous 
supply becomes the major hurdle for a long-term culture study. This is due to the low 
concentration of reticulocytes circulating in peripheral blood, bone marrow and 
umbilical cord blood. Fortunately, the development system in in vitro culture to 
generate reticulocytes derived from haematopoietic stem cells (HSCs) could solve the 
limitation of the P. knowlesi study. In this study, umbilical cord blood (UCB) was used 
as the source of HSCs which contained the highest concentration of CD34+ compared 
to peripheral blood and bone marrow. First, UCB-derived CD34+ HSCs were 
expanded in serum-free expansion medium II (SFEM) supplement with cytokines 
allowing the cells to proliferate. After 5 days of expansion, the cells were cultured in 
differentiation media with sufficient growth factors and cytokines for the process of 
reticulocytes differentiation. Microscopic examination and FACS analysis were 
performed during the cultivation period to observe the morphological changes and 
monitor the expression of cell surface antigens. Lastly, P. knowlesi was cultured in the 
generated reticulocytes and the invasion rate was determined at 24-hour post-invasion. 
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Although the invasion of P. knowlesi was not performed due to unforeseen 
circumstances, the result showed that functional reticulocytes could be generated from 
UCB-derived CD34+ HSCs and the invasion rate of P. knowlesi was expected to be 
similar with P. vivax. This is because P. knowlesi has the closest phylogenetically with 
P. vivax. In conclusion, this study shows the possibility to produce massive production 








1.1 Background of the study 
 
Malaria was discovered over 2000 years ago since Greek and Roman 
civilisation had fever caused by the malaria parasite from the genus Plasmodium.  
According to the World Malaria Report 2019, the disease occurred mostly in the 
African region (93% cases) followed by the Southeast Asia region (3.4% cases) and 
Eastern Mediterranean region (2.1% cases) (World Health Organization (WHO), 
2019). The malaria cases were reported to decline to 57 cases from 71 cases per 1000 
population from 2010 to 2018 in all of the WHO regions. Despite the declining cases, 
it was deteriorated in 2014 when it remained at a similar rate until 2018 (WHO, 2019).  
 
The malaria parasite is a vector and host specific. The vectors for the 
malaria parasites belong to a group of mosquitoes known as Anopheles leucosphyrus 
(Cooper et al., 2020). Humans are the natural hosts for the human malaria parasites 
such as P. falciparum, P. vivax, P. malariae and P. ovale. Long-tailed macaque 
(Macaca fascularis) and pig-tailed macaque (Macaca nemestrina) are the natural hosts 
for P. knowlesi that has now been recognised as the fifth human malaria parasite (Amir 
et al., 2018; Singh and Daneshvar, 2013). Common infections by P. falciparum and P. 
vivax have been reported yearly (Grüring et al., 2014). But starting in 2004, the highest 
cases of P. knowlesi were reported especially in Kapit Division, Sarawak, Malaysian 
Borneo (Grüring et al., 2014) and now spread to other parts in Southeast countries 
(Cooper et al., 2020). 
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P. knowlesi have the closest phylogenetically connected to P. vivax (Moon 
et al., 2013; Noulin et al., 2014)). They are similar in term of the host cell invasion 
that depends on the parasite ligand, Duffy binding protein (DBP) (Mohring et al., 
2019). P. knowlesi has the 24 hours intraerythrocytic life cycle as compared with that 
of P. falciparum, P. vivax, P. ovale (48 hours) and of P. malariae (72 hours) (Mohring 
et al., 2019; Moon et al., 2013). The intraerythrocytic cycle begins after sporozoites 
are transmitted into a human via an infected female Anopheles mosquito. The parasites 
reach the liver and invade hepatocytes before maturing into schizonts. Merozoites 
released from the schizonts enter the bloodstream and invade erythrocytes. Following 
erythrocyte invasion, the parasites grow into ring forms and then develop into mature 
trophozoites and schizonts filled with merozoites (Singh and Daneshvar, 2013).  
 
In vitro continuous culture of P. falciparum permits many studies of the 
biology of this parasite and the testing of compounds for antimalarial activity (Duffy 
and Avery, 2017). However, no in vitro continuous culture of P. knowlesi or P. vivax 
has been established thus far (Kumar et al., 2015; Moon et al., 2013). Attempts were 
made to maintain P. knowlesi in vivo in rhesus macaques (M. mulata) (Amir et al., 
2016). This requirement involved an expensive cost for daily animal care and therefore 
restricted research to primate laboratory facilities (Grüring et al., 2014; Moon et al., 
2013). P. knowlesi also has a difficulty in adaptation to an in vitro culture by using 
human erythrocytes as it has a specificity to invade reticulocytes (young erythrocytes) 
(Grüring et al., 2014; Lim et al., 2013). The low concentration of reticulocytes in 
peripheral blood has restricted the use of these cells for establishment of P. knowlesi 
in vitro culture (Noulin et al., 2012).  
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Haematopoietic stem cells (HSCs) have a capacity to expand and 
differentiate into reticulocytes by using appropriate microenvironments such as 
erythropoietin (EPO) and stem cell factor (SCF) (Dorn et al., 2008; Trakarnsanga et 
al., 2017). HSCs have the potential to self-replicate, self-renewal and are able to 
differentiate into multiple cell lines. High volume of HSCs can be obtained from 
umbilical cord blood (UCB), a rich source of HSCs to generate enough amount of 
reticulocytes for in vitro culture (Hordyjewska et al., 2015). HSCs can be determined 
by the expression of a surface marker, CD34 antigen by using flow cytometry 
(Hordyjewska et al., 2015). Other important markers such as CD235a represented 
glycophorin A and CD71 is a transferrin receptor are also expressed on reticulocytes 
(Noulin et al., 2012).  
 
1.2 Rationale of the study 
 
Elimination of malaria is thought to be achieved when malaria cases 
decreased in number since 2010. It however does not last long when the number of 
malaria cases stopped to decline in 2014. The emergence of zoonotic malaria has now 
become a threat when P. knowlesi has the capability to cause infection in humans. 
Research towards this parasite has become more challenging due to its requirement of 
macaque blood and laboratory facility. Scarce replication rate of P. knowlesi in vitro 
has been shown, which might be due to the parasite’s preference towards reticulocytes 
compared to mature erythrocytes. Therefore, the differentiation of CD34+ HSCs from 
UCB source was conducted in the present study to generate reticulocyte lines. The 
CD34 antigen expressed on the surface of UCB-derived HSCs has the closest value 
with bone marrow than that with peripheral blood (Hordyjewska et al., 2015). Thus, 
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the higher proportion and ability of UCB-derived HSCs to differentiate into 
reticulocytes provides an alternative strategy to obtain high amount of reticulocyte for 
P. knowlesi invasion assay and subsequently for in vitro culture.  
 
1.3 Objectives of the study 
 
1.3.1 General objective 
 
To determine the invasion of functional reticulocytes derived from human UCB 
CD34+ HSC line by P. knowlesi 
 
1.3.2 Specific objectives 
 
i. To expand and differentiate human UCB CD34+ HSCs into reticulocytes 
ii. To characterise functional reticulocytes differentiated from human UCB 
CD34+ HSCs 
iii. To observe the invasion of generated reticulocytes by P. knowlesi  
 
1.4 Experimental design 
 
The study was designed to differentiate human UCB CD34+ HSCs into 
reticulocytes and to determine the function of generated reticulocytes by using P. 
knowlesi invasion assay. The overall study is summarised in Figure 1.1. The HSCs 
were expanded for five days in serum-free expansion medium II (SFEM) 





















Figure 1.1: Flowchart of the experiment 
After 5 days of expansion, the cells were cultured in IMDM allowing cells to 
differentiate into erythroid line. The functional reticulocytes were characterised by 
performing FACS analysis and microscopic examination. The collection of P. 
knowlesi samples were performed by qualified nurses at Hospital Gua Musang (HGM) 
and Hospital Kuala Krai (HKK). The infected RBC with P. falciparum was purified 
using magnetic column separation. The percentage of parasitaemia was observed 
under 100X light microscope at 24 hours post-invasion. 
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and interleukin-6 (IL6) at 37oC in 5% CO2 incubator. The medium was partially 
replenished every day and the cells were passaged every three days. On day five of 
expansion, the medium was changed into Iscove’s Modified Dulbecco’s Medium 
(IMDM) supplemented with L-glutamine, penicillin/streptomycin, inositol, 
transferrin, monothioglycerol, folic acid, insulin human solution and 10% BSA in 
IMDM. During the first 8 days of differentiation, the complete culture medium was 
supplemented with growth factors such as hydrocortisone (HDS), interleukin-3 (IL3), 
SCF and EPO allowing cells to differentiate into erythroid line. Starting day 8 until 11 
of differentiation, the cells were cultured in IMDM supplemented with EPO only and 
then were maintained in IMDM without any supplements added to the medium until 
day 14. The medium was partially replenished every two days to supply enough 
nutrients to the cells and maintained under standard culture conditions in 37oC of 5% 
CO2 incubator. 
 
Fluorescence-activated cell sorting (FACS) was performed on particular 
days: days 0, 8, 11, 14, 16 and 20 to analyse the expression of CD34, CD45, CD36, 
CD71 and CD235a surface antigens during differentiation phase. Primary antibodies 
CD45 PerCP-Cy5.5, CD71 FITC, CD36 APC, and CD235a PE were used. Mouse 
IgG1 PerCP-Cy5.5, mouse IgG2a FITC, mouse IgM APC, and mouse IgG2b PE 
isotype controls were used as negative controls. Subsequently, the pellet was incubated 
in phosphate-buffered saline (PBS) and stained with Brilliant Cresyl Blue solution for 
30 minutes before being examined under 100X magnification using light microscope. 
The morphology of cell derived from human UCB CD34+ HSCs was observed. The 
differentiation ended on day 14 corresponding to the peak of reticulocyte counts 
determined by microscopic examination. 
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P.knowlesi samples were collected from patients at Hospital Gua Musang 
(HGM) and Hospital Kuala Krai (HKK), while, P. falciparum (control) was 
synchronised at ring stage by using sorbitol treatment to obtain mature stage parasites 
after 24 hours post-synchronisation. In order to get purified and infected erythrocytes, 
the mature stage parasites were harvested by using a magnetic column separation. The 
purified parasites were cultured with reticulocytes derived from human UCB CD34+ 
HSCs. The parasite invasion was determined at 24 hours post-invasion by using 







2.1 Overview of malaria 
 
Humans had suffered from malaria disease since years back. The disease 
is caused by protozoa of the genus Plasmodium and occurs mostly in sub-Saharan 
Africa and throughout the Indian subcontinent, Southeast Asia and South America 
(Ryan et al., 2015; WHO, 2019). Human malaria parasites undergo sexual 
development in female Anopheles mosquitoes before infecting humans in which the 
asexual development begins (Roncalés et al., 2015). Various studies such as genetic 
modification, biology of the malaria parasites and antimalarial drug screening have 
been carried out to unravel the disease (Moon et al., 2013). The emergence of zoonotic 
infections caused by P. knowlesi is currently a major problem (Ahmed and Cox‐Singh, 
2015). This malaria parasite has limited laboratory strains that might no longer be 
representative of current parasite populations (Vythilingam et al., 2018). Therefore, 
studies on the adaptation of P. knowlesi to an in vitro culture by using human 
erythrocytes rather than its natural macaque erythrocytes are urgently needed. 
 
2.2 Epidemiology of malaria 
 
According to the World Health Organization (WHO), 228 million cases of 
malaria were reported worldwide in 2018 with 85% deaths occurred in 20 countries in 
the African region and India subcontinent (WHO, 2019). The African region recorded 
the highest malaria cases (93%) followed by Southeast Asia (3.4%) and Eastern 
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Mediterranean regions (2.1%) (WHO, 2019). The malaria case incidence rate started 
to decrease from 71 cases to 57 cases per 1000 population between 2010 until 2018, 
however, it remained at a similar level since 2014 until 2018 (WHO, 2019). The global 
malaria case incidence rate for the population at risk is shown in Figure 2.1. 
 
Among all human malaria parasites, P. falciparum is the main species 
reported to be the most life-threatening, causing approximately 99% malaria cases in 
sub-Saharan Africa (Mohring et al., 2019). Malaria cases outside Africa are 
predominantly due to P. vivax with 200 million global cases reported annually 
(Dayanand et al., 2018). While, other non-falciparum malaria infections caused by P. 
ovale and P. malariae were reported to be malaria-endemic cases in Western Africa, 
South America, Asia and western Pacific region. These species are less virulent and  
rarely become the attention because of the scarce cases (Lo et al., 2017; Okafor and 
Finnigan, 2019). The current emergence of the fifth human malaria parasite, P. 
knowlesi has been widely spread to Southeast Asia, including Indonesia, Cambodia, 
Philippines, Singapore, Thailand, Vietnam and Myanmar (Barber et al., 2017; Millar 
and Cox-Singh, 2015). In Malaysia, malaria cases due to this species showed a high 
number of 100 cases per year in the 2000s, rising to 703 cases in 2011, 1325 cases in 
2014 and 2030 in 2017 with six deaths recorded in 2015 until 2017 (Cooper et al., 
2020). The high risk populations are children under 5 years old and pregnant women 
with 24 million cases and 11 million cases, respectively reported in 2018 (Roncalés et 
















Figure 2.1: The worldwide malaria case incidence rates in 2018 
The map shows high malaria cases in the African region. The Eastern Mediterranean region, Western Pacific region, American region and Southeast 
Asia region showed active transmission of malaria cases in 2018. Adapted from WHO (2019). 
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2.3 Symptoms of malaria 
 
Patients will show clinical symptoms when the asexual intraerythrocytic 
cycle of the malaria parasite is initiated (Mace, 2019). The common symptom to all 
human malaria parasites is a nonspecific mimicking flu-like syndrome and high fever 
(Cowman et al., 2016; Mace, 2019). The different pattern in fever spike is due to the 
different period of the intraerythrocytic cycle of the malaria parasites: P. knowlesi (24 
hours), P. falciparum, P. vivax and P. ovale (48 hours), and P. malariae (72 hours) 
(Ahmed and Cox‐Singh, 2015; Singh and Daneshvar, 2013). Along with fever and 
chills, patients will experience prodromal symptoms such as malaise, myalgia, 
anorexia, nausea, occasional vomiting, sweating, headache, fatigue, cough and mild 
anaemia. The severity of malaria symptoms varies from absent or mild symptoms to 
severe and deadly. Malaria parasite species, patient’s age and immune response to 
infection are some of the factors contributing to the severity of the disease. Malaria 
can lead to organ failure and death if it is left untreated (Cowman et al., 2016; Mace, 
2019). 
 
2.4 Human malaria parasites 
 
Malaria parasites are transmitted into humans via the bite of female 
Anopheles mosquitoes from the Leucosphyrus group (Roncalés et al., 2015; Singh and 
Daneshvar, 2013). There are four malaria parasites naturally hosted in humans: P. 
falciparum, P. vivax, P. malariae and P. ovale. P. knowlesi naturally inhabits in long-
tailed macaques (Macaca fascicularis) and pig-tailed macaques (Macaca nemestrina) 
(Amir et al., 2018; Singh and Daneshvar, 2013). P. knowlesi has become the fifth 
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human malaria parasite after the huge cases of zoonotic malaria were reported in the 
Kapit Division of Sarawak in 2004 (Singh and Daneshvar, 2013). These cases with 
four deaths were misdiagnosed as P. malariae, the malaria parasite that rarely causes 
fatal (Cox-Singh et al., 2008). Later, it was revealed to be caused by P. knowlesi as 
this malaria parasite is easily misdiagnosed as P. malariae due to their morphological 
similarity when observed by conventional microscopy (Millar and Cox-Singh, 2015). 
Another case of misdiagnosis of P. knowlesi as P. malariae was reported in 2007 (Ng 
et al., 2008). 
 
2.5 Life cycle of the human malaria parasites 
 
The human malaria parasites have a complex life cycle that grow and 
reproduce through two important phases: sexually and asexually. The malaria parasites 
undergo the sexual phase within mosquito vectors and the asexual phase within human 
hosts (Howick et al., 2019; Roncalés et al., 2015). 
 
2.5.1 Sexual cycle of the malaria parasites within mosquitoes 
 
The malaria parasites undergo gametocytogenesis following transmission 
of gametocytes from humans to mosquitoes (Figure 2.2). After the differentiation of 
microgametocytes (male) and macrogametocytes (female) into microgametes and 
macrogametes, respectively, each microgamete exflagellates to produce eight 
microgametes and fuses with the macrogamete, forming a zygote (Guttery et al., 2015; 
Siciliano and Alano, 2015). Soon after zygote formation, a motile ookinete is formed 














Figure 2.2: The sexual cycle of the malaria parasite within a mosquito 
A microgamete (male) fuses with a macrogamete (female) forming a zygote. The elongated zygote transforms into an ookinete. The ookinete 
migrates through the mosquito’s midgut and develops into an oocyst. Upon maturation of the oocyst, the parasite ruptures releasing numerous 
sporozoites. The sporozoites travel to the mosquito’s salivary gland and ready to be injected into a human during a blood meal. Modified from 
Karanja and Kiboi (2016).     
Sexual Cycle in Mosquito 
14 
 
undergoes division and maturation, which gives rise to numerous sporozoites within 
two weeks of the sporogony. The sexual cycle is completed when thousands of 
sporozoites invade the mosquito’s salivary glands and are injected into humans during 
blood meal (Kengne-Ouafo et al., 2019; Lampe et al., 2019). 
 
2.5.2 Asexual cycle of the malaria parasites within humans 
 
Sporozoites are injected into venules of a human during a blood meal 
(Figure 2.3). Within an hour, sporozoites reach the liver and invade the hepatocytes. 
The parasites undergo the exoerythrocytic schizogony to produce numerous 
multinucleated schizonts. It takes approximately 15 days for the parasites to mature 
and develop into schizonts containing merozoites before initiating the intraerythrocytic 
schizogony. The membrane of the schizonts ruptures, releasing merozoites into the 
bloodstream to invade erythrocytes (Cowman et al., 2016; White, 2017). Within the 
erythrocyte, the parasite transforms into ring, trophozoite and schizont stages. The 
schizont stage-infected erythrocytes rupture, releasing merozoites to reinvade new 
erythrocytes. The developmental cycle of the malaria parasites is different depending 
on the species. P. knowlesi has the shortest 24-hour life cycle, while P. malariae has 
the longest 72-hour life cycle. Other human malaria parasites, P. falciparum, P. vivax 
and P. ovale have the 48-hour life cycle (Ahmed and Cox‐Singh, 2015; White, 2017). 
 
2.6 Reported studies on P. knowlesi 
 
Almost all countries in Southeast Asia have reported cases of P. knowlesi 




















Figure 2.3: The asexual cycle of the malaria parasite within a human 
(1) Anopheles mosquito injects sporozoites during a blood meal. (2) Injected 
sporozoites enter the liver and (3) invade hepatocytes and develop into schizonts. (4) 
Within 15 days of the incubation, the schizonts mature and rupture releasing numerous 
merozoites into the bloodstream to invade erythrocytes. The development of the 
malaria parasite continues inside infected erythrocytes, where merozoites transform 
into ring, trophozoite and schizont containing merozoites. The infected erythrocytes 
rupture, releasing merozoites to invade new erythrocytes. (5) Male and female 
gametocytes differentiated from merozoites were ingested by a mosquito. Adapted 
from Faust (2016). 
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shows the ability to infect humans, causing the emergence of zoonotic malaria. This 
hinders the goal to eradicate malaria and obtain the status of malaria-free countries 
(Barber et al., 2017). The increasing malaria cases of P. knowlesi seem to show that 
the eradication of malaria is unsuccessful towards zoonotic malaria, thus, different 
approaches are needed (Cooper et al., 2020). 
 
In vitro culture provides investigation on the development of the malaria 
parasite as well as other significant research on malaria (Lapp et al., 2015). There are 
several challenges in culturing P. knowlesi in vitro. The use of natural host macaque 
blood has limited the studies with access to the animal facility (Moon et al., 2013). P. 
knowlesi has also been demonstrated in vitro to have a predilection towards 
reticulocytes (Grüring et al., 2014). The tendency of P. knowlesi to invade 
reticulocytes is higher compared to mature erythrocytes. The Duffy binding protein 
(DBP) (parasite ligand) on merozoites showed a high interaction to the Duffy antigen 
receptor for chemokines (DARC) (host receptor) on reticulocytes during invasion 
(Cowman et al., 2017; Ovchynnikova et al., 2017). Reticulocyte concentration in 
peripheral blood is, however, very low (0.5-2.5%) with the 24-hour lifespan prior to 
maturation (Kumar et al., 2015; Noulin et al., 2014), making the establishment of a 
continuous in vitro culture of P. knowlesi by using reticulocytes difficult. This 
becomes a major challenge although there has been a technique known as 
cryopreservation, which has the ability to store and freeze samples enriched with 
reticulocytes. Despite that, a high reproducibility of enriched reticulocytes must be 
obtained to collect sufficient reticulocytes prior to freezing (Kumar et al., 2015). 
Therefore, alternative methods to produce high volumes of reticulocytes such as 
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through expansion and differentiation of haematopoietic stem cells (HSCs) are 
implemented. 
 
2.7 The origin of stem cells 
 
Human body is made up from different types of cells that are originated 
from stem cells. Stem cells have the ability to regenerate and differentiate into any 
type of cells for maintaining homeostasis in the body and replacing cells or tissues that 
are damaged or lost (Zhang et al., 2017). There are three different types of stem cells. 
Firstly, embryonic stem cells (ESCs) that are the inner cell mass of early blastocyst 
and pluripotent, which are able to differentiate into all types of tissues. Secondly, 
somatic or adult stem cells (SSCs), which are multipotent and only able to differentiate 
into specific cells in the body during cell damage in order to maintain tissue 
homeostasis. Two types of SSCs are haematopoietic stem cells (HSCs) and 
mesenchymal stem cells (MSCs). Lastly, induced pluripotent stem cells (iPSCs), 
which are reprogrammed stem cells that are taken from normal mature adult cells to 




Haematopoiesis is a process of blood cell formation to replenish the blood 
system.  The first haematopoiesis occurs in the yolk sack, followed by liver and lastly 
in the bone marrow and thymus (Jagannathan-Bogdan and Zon, 2013). During 
embryonic development, the blastomeres, known as totipotency, are the first stem cells 
that are important in developing into any type of cells for human body development 
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(Figure 2.4). At the gastrulation stage, the totipotency lost the properties of the cell 
and initiates the process into specialised cells: trophoblast (developed into placenta) 
and embryonic node (pluripotent cells). Pluripotent cells have the ability to divide 
continuously and differentiate into any type of cells derived from the ectoderm, 
mesoderm and endoderm. However, these pluripotent cells are unable to differentiate 
into germ cells in the placenta once they move to the uterus. These pluripotent cells 
gradually continue to develop into tissue stem cells (multipotent cells) and subdivided 
asynchronously into two progenies, which are one HSCs and one haematopoietic 
progenitor cells (HPCs). HPC is a unipotent cell due to its inability to self-renew and 
can differentiate into one or more extra lineage only. Myelocytic precursor colony-
forming unit of granulocyte, erythroid, macrophage and megakaryocyte (CFU-
GEMM) or lymphoid precursor (CFU-Lymph) are the precursors differentiated from 
HPCs (Hordyjewska et al., 2015).  
 
2.9 Characteristics of Haematopoietic Stem Cells 
 
The unique capability of HSCs is to produce daughter cells continuously 
while preserving the stem cell characteristics. The HSCs are able to self-renewing, 
thus do not become specialised or differentiate which resulting in a lifetime source of 
blood cells (Copelan, 2006). Various sources of stem cells can be used to generate 
HSCs into different stages of the erythroid lineage. HSCs can be obtained from 
peripheral blood (PB), bone marrow (BM), umbilical cord blood (UCB) or induced 
pluripotent stem cells (Giarratana et al., 2011). UCB-derived HSCs have shown a 
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Figure 2.4: The development of haematopoietic stem cells (HSCs) 
Blastomeres are the first stem cells known as a totipotent. They are initiated into 
specialised cells such as embryonic node, which are also called pluripotent stem cells. 
These pluripotent stem cells start to differentiate into any type of cells derived from 
the ectoderm, mesoderm and endoderm. After that, the pluripotent stem cells continue 
to develop into tissue stem cells known as multipotent, which contains two progenies; 
haematopoietic stem cells (HSCs) and haematopoietic progenitor cells (HPCs). HPCs 
give rise either to myeloid precursor colony-forming unit of granulocyte, erythroid, 
macrophage and megakaryocyte (CFU-GEMM) or lymphoid precursor colony-
forming unit of lymphocyte (CFU-Lymph). These two precursors arisen from HPCs 




HSCs is located at the postpartum placenta and cord of UCB (Trakarnsanga et al., 
2017). 
 
HSCs and haematopoietic progenitor cells (HPCs) are known to express 
specific surface marker, CD34. Specifically, it is a transmembrane 
phosphoglycoprotein and has approximately 115 kDa of molecular weight. CD34 
plays an important role in cytoadhesion and regulation of cell differentiation since 
most of the ability of an extracellular domain is O-linked glycosylated and certain sites 
contain N-linked glycosylated (Sidney et al., 2014). Upon the significant function of 
CD34, recent studies suggested that the appearance of CD34+ is prior to cell division. 
Therefore, CD34 expression is important as the relatedness to other functions of HSCs 
such as undergo cell cycle entry, metabolic activation, mobilization and homing 
(AbuSamra et al., 2017). In addition, in vivo cultivation has shown that CD34+ HSCs 
and HPCs also have the ability to differentiate into other lineages despite 
haematopoietic lineage and have a great capacity to proliferate (Sidney et al., 2014). 
Hence, the expression of CD34+ on HSCs is a reliable precursor to generate 




A healthy human body produces 2 million mature erythrocytes every 
second through a regulated process called erythropoiesis (Moras et al., 2017). It begins 
when multipotent HSCs differentiate from myeloid progenitors (megakaryocytic-
erythroid progenitor) into burst-forming unit-erythroid (BFU-E) to form mature 













Figure 2.5: The terminal erythroid stage of erythropoiesis 
HSCs differentiate into committed erythroid progenitors known as burst-forming unit-erythroid (BFU-E) and colony-forming unit-erythroid (CFU-
E). The nucleated precursors, proerythroblasts differentiates into basophilic erythroblast, polychromatic and orthochromatic erythroblast by 
undergoing several morphological changes such as accumulation of haemoglobin and cell size reduction. This process occurs in the surrounding 
of central macrophages in erythroblastic islands before entering the blood stream while continue to achieve maturation and becoming erythrocytes. 
Adapted from Zivot et al. (2018).  
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BFU-E are the first erythroid lineage that differentiates into colony-forming unit-
erythroid (CFU-E) (terminal erythroblast differentiation). Later, the nucleated 
precursors, proerythroblasts differentiate into basophilic, polychromatophilic and 
orthrochromatophilic erythroblasts. The differentiation of nucleated precursors 
undergoes several morphological changes such as haemoglobin synthesis, cell size 
reduction, chromatin and nuclear condensation resulting in enucleation to form 
reticulocytes (Rai et al., 2019). At the end of the terminal erythroid stage, erythroblasts 
lose their nucleus and reticulocytes continue to undergo maturation, forming an 
erythrocyte-biconcave shape. The erythropoiesis takes place in erythroblastic islands 
which consists of central macrophages and 30 erythroid cells at a different stage of 
maturation. The environment in erythroblastic islands provides cellular interactions 
that are necessary for erythroid differentiation and proliferation (Moras et al., 2017; 
Zivot et al., 2018). 
 
2.11 Characterisation of reticulocytes derived from HSCs 
 
A successful production of reticulocytes through differentiation of HSCs 
has been reported previously (Noulin et al., 2012). To produce erythrocytes, HSCs are 
induced to erythroid differentiation, allowing them to proliferate and differentiate into 
erythrocyte lines. To produce functional reticulocytes from HSC cultivation, the 
culture process must mimic the medullar environment. The process of cultivation 
requires particular erythropoietin cytokines with or without human mesenchymal stem 
cells as feeder cells to enhance reticulocyte proliferation and differentiation. 
Reticulocytes derived from HSCs have been shown to be more homogenous. Other 
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studies had reported an increasing percentage of reticulocyte production from 
cryopreserved erythroblasts (Furuya et al., 2014; Noulin et al., 2014). 
 
Umbilical cord blood (UCB) is known to be the richest source to obtain 
HSCs. HSCs appear as small cells with narrow haem cytoplasm and are able to 
proliferate into different types of lineage. Differentiation of multi-line HSCs can be 
assessed by the natural characteristic via the expression of specific surface markers 
throughout the differentiation process (Hordyjewska et al., 2015). Based on the 
reticulocyte characteristic, there are several cell surface antigens expressed at a 
different stage prior to maturation of erythrocytes: CD36, CD45, CD71 and CD235a. 
During preerythroblast until proerythroblast stages, the CD45 is highly expressed but 
then decreases dramatically, while another surface antigen, CD235a (Glycophorin A) 
continues to express afterward. The following cell surface antigens, CD71 and CD36 
are markers for proerythroblast and mature erythrocytes respectively where they are 
highly expressed during the young cells stage yet start to decline prior to maturation 
stages (Noulin et al., 2012). Erythroid cells can also be differentiated by morphology 





MATERIALS AND METHODS 
 
3.1 Reagents and equipment 
 
Chemicals and reagents, antibodies, equipment and software used 
throughout the study were listed in Table 3.1, Table 3.2, Table 3.3 and Table 3.4, 
respectively. 
 
3.2 P. falciparum in vitro cultivation 
 
3.2.1 Malaria parasite strain 
 
The P. falciparum 3D7 strain was used as a control parasite in the study. 
The parasite was kindly provided by Dr. Khairul Mohd Fadzli Mustaffa from the 
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia 
(USM). 
 
3.2.2 Thawing of cryopreserved malaria parasites 
 
Cryopreserved parasites were thawed immediately in a 37°C water bath 
for 1 minute after removing from the liquid nitrogen tank (Amir et al., 2016). The 
content of thawed parasites was transferred into 15 mL falcon tubes and the volume of 
content was measured. An equal volume of 3.5% sodium chloride (NaCl) was then 
added dropwise. The suspensions were centrifuged at 332 × g for 5 minutes and  
